Ms. Carm. 1 (Ausst. 47) - Das Buch der Natur

ausgelöste Fragmente unter: Fragm. germ. IV 5; Vorbesitzer: Karmeliterkloster Frankfurt am Main

Ms. hebr. oct. 38 - Ḥasde Adonai

Vorbesitzer: Abraham Merzbacher

Ms.Ff.F.Stoltze 3. 341 - Brief von Friedrich Stoltze an Vereinigte Stadttheater

Hilfe für eine bedürftige Familie, Bitte um Ausleihung von Kostümen für eine Benefizvorstellung

Ms. germ. oct. 31 (Ausst. 38) - Leben und Leiden Christi. Gebete

Vorbesitzer: Johann Maximilian zum Jungen

37,X/38,XY Mosaicism in a Cryptorchid Bengal Cat with Müllerian Duct Remnants

A 23-month-old tomcat was referred to our clinic because of male behavioral problems, cryptorchidism, and an undefined intra-abdominal organ resembling a uterus. Ultrasonography and computed tomography showed 2 fluid-filled tubular structures dorsolaterally to the bladder and connected to the pelvic urethra. The cat was castrated, and the tubular structures were surgically removed. Histology identified them as Müllerian duct remnants. The testes were hypoplastic, the epididymes and deferent ducts were normal. Cytogenetic analyses revealed the presence of a mosaic 37,X/38,XY karyotype which explains the clinical findings.

Kundmachung: Jakob Flebus, von Triest gebürtig, 38 Jahre alt, katholisch ...

Welsch (Projektbearbeiter): Verurteilung des Hutmachers Flebus zu vierjährigem schwerem Kerker wegen Aufruhrs und bewaffneten Widerstands gegen das Militär sowie des Bäckers Wranz und des Kammerdieners Kalpacher zu sechs- bzw. dreimonatigem Arrest in Eisen wegen illegalen Waffenbesitzes. Aufhebung der Verurteilung des Bäckers und Hausmeisters Nießner zu achttägigem Arrest in Eisen (ebenfalls wegen illegalen Waffenbesitzes) auf dem Gnadenwege

Final Results of a Prospective Evaluation of the Predictive Value of Interim Positron Emission Tomography in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP-14 (SAKK 38/07)

PURPOSE Our main objective was to prospectively determine the prognostic value of [(18)F]fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) after two cycles of rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone given every 14 days (R-CHOP-14) under standardized treatment and PET evaluation criteria. PATIENTS AND METHODS Patients with any stage of diffuse large B-cell lymphoma were treated with six cycles of R-CHOP-14 followed by two cycles of rituximab. PET/CT examinations were performed at baseline, after two cycles (and after four cycles if the patient was PET-positive after two cycles), and at the end of treatment. PET/CT examinations were evaluated locally and by central review. The primary end point was event-free survival at 2 years (2-year EFS). RESULTS Median age of the 138 evaluable patients was 58.5 years with a WHO performance status of 0, 1, or 2 in 56%, 36%, or 8% of the patients, respectively. By local assessment, 83 PET/CT scans (60%) were reported as positive and 55 (40%) as negative after two cycles of R-CHOP-14. Two-year EFS was significantly shorter for PET-positive compared with PET-negative patients (48% v 74%; P = .004). Overall survival at 2 years was not significantly different, with 88% for PET-positive versus 91% for PET-negative patients (P = .46). By using central review and the Deauville criteria, 2-year EFS was 41% versus 76% (P < .001) for patients who had interim PET/CT scans after two cycles of R-CHOP-14 and 24% versus 72% (P < .001) for patients who had PET/CT scans at the end of treatment. CONCLUSION Our results confirmed that an interim PET/CT scan has limited prognostic value in patients with diffuse large B-cell lymphoma homogeneously treated with six cycles of R-CHOP-14 in a large prospective trial. At this point, interim PET/CT scanning is not ready for clinical use to guide treatment decisions in individual patients.

Kundmachung: Franz Xaver Sinsler, aus Friedek in k. k. Schlesien gebürtig, 38 Jahre alt ...

Welsch (Projektbearbeiter): Verurteilung des Mechanikers Sinsler zu fünfjähriger Zwangsarbeit wegen bewaffneten Aufruhrs; Erlaß der Strafe auf dem Wege der Begnadigung

Hs. Rothschild 4° 38 - Bibliothèque de Madame la Baronne Adélaïde de Rothschild [Catalogue]

Vorbesitzer: Adélaïde de Rothschild; Freiherrlich Carl von Rothschild'sche Bibliothek Frankfurt am Main; alte Signatur: 82; Hs in 4° 38; Akzessionsnummer: X19126

Record linkage to correct under-ascertainment of cancers in HIV cohorts: the Sinikithemba HIV clinic linkage project.

The surveillance of HIV-related cancers in South Africa is hampered by the lack of systematic collection of cancer diagnoses in HIV cohorts and the absence of HIV status in cancer registries. To improve cancer ascertainment and estimate cancer incidence, we linked records of adults (aged ≥ 16 years) on antiretroviral treatment (ART) enrolled at Sinikithemba HIV clinic, McCord Hospital in KwaZulu-Natal (KZN) with the cancer records of public laboratories in KZN province using probabilistic record linkage methods. We calculated incidence rates for all cancers, Kaposi sarcoma (KS), cervix, non-Hodgkin's lymphoma and non-AIDS defining cancers (NADCs) before and after inclusion of linkage-identified cancers with 95% confidence intervals (CI). A total of 8,721 records of HIV-positive patients were linked with 35,536 cancer records. Between 2004 and 2010 we identified 448 cancers, 82% (n=367) were recorded in the cancer registry only, 10% (n=43) in the HIV cohort only and 8% (n=38) both in the HIV cohort and the cancer registry. The overall cancer incidence rate in patients starting ART increased from 134 (95% CI 91-212) to 877 (95% CI 744-1,041) after inclusion of linkage-identified cancers. Incidence rates were highest for KS (432, 95% CI 341-555), followed by cervix (259, 95% CI 179-390) and NADCs (294, 95% CI 223-395) per 100,000 person-years. Ascertainment of cancer in HIV cohorts is incomplete, probabilistic record linkage is both feasible and essential for cancer ascertainment. This article is protected by copyright. All rights reserved.

Bemerkungen zum Orient 1841, Literaturblatt Nr. 38

Theodor Cohn

Ms. Barth. 38 - Casus Decretorum

Vorbesitzer: Bartholomaeusstift Frankfurt am Main